Does SULFASALAZINE Cause Bladder transitional cell carcinoma? 55 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Bladder transitional cell carcinoma have been filed in association with SULFASALAZINE (Azulfidine EN-tabs). This represents 0.1% of all adverse event reports for SULFASALAZINE.
55
Reports of Bladder transitional cell carcinoma with SULFASALAZINE
0.1%
of all SULFASALAZINE reports
3
Deaths
51
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From SULFASALAZINE?
Of the 55 reports, 3 (5.5%) resulted in death, 51 (92.7%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SULFASALAZINE. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does SULFASALAZINE Cause?
Drug ineffective (22,365)
Rheumatoid arthritis (15,136)
Drug intolerance (11,530)
Pain (11,309)
Fatigue (9,684)
Joint swelling (9,673)
Rash (8,739)
Contraindicated product administered (8,698)
Arthralgia (8,527)
Abdominal discomfort (8,404)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
RANITIDINE (41)
Which SULFASALAZINE Alternatives Have Lower Bladder transitional cell carcinoma Risk?
SULFASALAZINE vs SULFATHIAZOLE
SULFASALAZINE vs SULFISOMIDINE
SULFASALAZINE vs SULFUR
SULFASALAZINE vs SULFUR HEXAFLUORIDE
SULFASALAZINE vs SULINDAC